GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease

Clinical trial NCT00950807 · COMPLETED

Trial details

NCT number: NCT00950807
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2009-09-01
Primary completion: 2010-03-01
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.